Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$2.8M
Filings
87
Firms Hired
3
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Support for S. 297/H.R. 1300 - PSA Screening for HIM Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1300
Support for S. 297/H.R. 1300 - PSA Screening for HIM Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 297
Support for S. 297/H.R. 1300 - PSA Screening for HIM Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1300
Support for S. 297/H.R. 1300 - PSA Screening for HIM Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 297
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2821
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
Tax Relief for American Families and Workers Act of 2024
2024 · third_quarter · Firm: THE MCMANUS GROUP
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: H.R.7024
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2821
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: S.866
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
Tax Relief for American Families and Workers Act of 2024
2024 · second_quarter · Firm: THE MCMANUS GROUP
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: H.R.7024
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2821
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: S.866
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
Tax Relief for American Families and Workers Act of 2024
2024 · first_quarter · Firm: THE MCMANUS GROUP
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: H.R.7024
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2821
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: S.866
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
American Innovation and R&D Competitiveness Act of 2023
2023 · fourth_quarter · Firm: THE MCMANUS GROUP
Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2673
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2821
Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023, S.866 - American Innovation and Jobs Act
Client expense: — · Firm income: $40,000
Matched citations: S.866
Support for H.R.1826 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
American Innovation and R&D Competitiveness Act of 2023
2023 · third_quarter · Firm: THE MCMANUS GROUP
Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2673
Support for H.R.1826 - PSA Screening for HIM Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1826
Source: Senate LDA